|
EP2550257B1
(en)
*
|
2010-03-22 |
2016-12-21 |
Lead Discovery Center GmbH |
Pharmaceutically active disubstituted triazine derivatives
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
US9108926B2
(en)
|
2011-09-16 |
2015-08-18 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
EP2755948B1
(en)
|
2011-09-16 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
US8598937B2
(en)
|
2011-10-07 |
2013-12-03 |
Transphorm Inc. |
High power semiconductor electronic components with increased reliability
|
|
US8803246B2
(en)
|
2012-07-16 |
2014-08-12 |
Transphorm Inc. |
Semiconductor electronic components with integrated current limiters
|
|
HK1209414A1
(en)
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN105102434A
(zh)
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
ES2616441T3
(es)
|
2012-10-18 |
2017-06-13 |
Bayer Pharma Aktiengesellschaft |
Derivados de N-(piridin-2-il))pirimidin-4-amina que contienen un grupo sulfona
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
AU2013346939B2
(en)
|
2012-11-15 |
2017-06-08 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
|
|
US9087718B2
(en)
|
2013-03-13 |
2015-07-21 |
Transphorm Inc. |
Enhancement-mode III-nitride devices
|
|
US9245993B2
(en)
|
2013-03-15 |
2016-01-26 |
Transphorm Inc. |
Carbon doping semiconductor devices
|
|
ES2630115T3
(es)
|
2013-07-04 |
2017-08-18 |
Bayer Pharma Aktiengesellschaft |
Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina con sulfoximina sustituida y su uso como inhibidores de quinasa cdk9
|
|
US9443938B2
(en)
|
2013-07-19 |
2016-09-13 |
Transphorm Inc. |
III-nitride transistor including a p-type depleting layer
|
|
EP3116869A1
(en)
|
2014-03-13 |
2017-01-18 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN106414412B
(zh)
|
2014-04-01 |
2019-06-21 |
拜耳医药股份有限公司 |
含有磺酰二亚胺基团的二取代的5-氟嘧啶衍生物
|
|
CR20160471A
(es)
|
2014-04-11 |
2016-12-21 |
Bayer Pharma AG |
Compuestos novedosos macrocíclicos
|
|
US9543940B2
(en)
|
2014-07-03 |
2017-01-10 |
Transphorm Inc. |
Switching circuits having ferrite beads
|
|
US9318593B2
(en)
|
2014-07-21 |
2016-04-19 |
Transphorm Inc. |
Forming enhancement mode III-nitride devices
|
|
CA2964683A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
CA2964696C
(en)
|
2014-10-16 |
2022-09-06 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
EP3274338A1
(en)
|
2015-03-24 |
2018-01-31 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
WO2016150903A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
PH12017502334B1
(en)
|
2015-06-29 |
2023-05-26 |
Astrazeneca Ab |
Polycyclic amide derivative as cdk9 inhibitors
|
|
CA2999931A1
(en)
|
2015-09-29 |
2017-04-06 |
Bayer Pharma Aktiengesellschaft |
Novel macrocyclic sulfondiimine compounds
|
|
JP6888000B2
(ja)
|
2015-10-08 |
2021-06-16 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な修飾された大環状化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
CN108604597B
(zh)
|
2016-01-15 |
2021-09-17 |
创世舫电子有限公司 |
具有al(1-x)sixo栅极绝缘体的增强模式iii-氮化物器件
|
|
WO2017210323A1
(en)
|
2016-05-31 |
2017-12-07 |
Transphorm Inc. |
Iii-nitride devices including a graded depleting layer
|
|
EP3601236A1
(en)
|
2017-03-28 |
2020-02-05 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
US11701347B2
(en)
|
2018-02-13 |
2023-07-18 |
Bayer Aktiengesellschaft |
Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
|